In support of this, the Panc02 and KPC1 tumours had increased CD8+ T‐cell infiltration and increased antitumour activation as measured by CD69 and IFNγ levels, whereas the KPC3 tumours did not show augmented CD8+ numbers but still had increased activation. The gene discussed is CD8A; the disease is neoplasm.